We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$53.9B
AUM Growth
-$21B
Cap. Flow
+$1.12B
Cap. Flow %
2.08%
Top 10 Hldgs %
31.63%
Holding
3,163
New
260
Increased
1,432
Reduced
926
Closed
418

Sector Composition

Rank Sector Weight
1 Technology 8.19%
2 Financials 4.43%
3 Consumer Discretionary 2.64%
4 Healthcare 2.52%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
2701
DELISTED
Asensus Surgical, Inc.
ASXC
$14.1K ﹤0.01%
44,196
+385
+0.9% +$99
XPL icon
2702
Solitario Resources
XPL
$68.1M
$14K ﹤0.01%
25,000
OSA
2703
DELISTED
ProSomnus, Inc. Common Stock
OSA
$13.7K ﹤0.01%
14,017
AMLI
2704
DELISTED
American Lithium Corp. Common Stock
AMLI
$13.2K ﹤0.01%
11,972
SQFT icon
2705
Presidio Property Trust
SQFT
$3.01M
$12.7K ﹤0.01%
1,229
CBD
2706
DELISTED
Companhia Brasileira de Distribuicao
CBD
$12.2K ﹤0.01%
15,251
SRXH
2707
SRX Global
SRXH
$35.1M
$12.1K ﹤0.01%
22
-6
-21% -$2.93K
NVTA
2708
DELISTED
Invitae Corporation
NVTA
$11.4K ﹤0.01%
18,163
-22,357
-55% -$13.4K
SHCR
2709
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$10.8K ﹤0.01%
10,000
XLG icon
2710
PUT
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
$10.8K ﹤0.01%
+25,000
New +$892K
VERU icon
2711
Veru
VERU
$36.1M
$10.7K ﹤0.01%
1,491
-173
-10% -$1.53K
HELP
2712
Cybin Inc
HELP
$472M
$10.7K ﹤0.01%
685
+165
+32% +$3.07K
FEMY icon
2713
Femasys
FEMY
$11.2M
$10.3K ﹤0.01%
526
KPTI icon
2714
Karyopharm Therapeutics
KPTI
$168M
$10K ﹤0.01%
773
WWR icon
2715
Westwater Resources
WWR
$51M
$9.5K ﹤0.01%
+16,819
New +$10.1K
LFWD icon
2716
ReWalk Robotics
LFWD
$19.8M
$9.38K ﹤0.01%
144
OTLK icon
2717
Outlook Therapeutics
OTLK
$264M
$8.62K ﹤0.01%
1,094
+19
+2% +$161
SDPI
2718
DELISTED
Superior Drilling Products Inc.
SDPI
$7.85K ﹤0.01%
11,000
+1,000
+10% +$735
SGMO
2719
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7.44K ﹤0.01%
13,690
INO icon
2720
Inovio Pharmaceuticals
INO
$79.8M
$7.16K ﹤0.01%
1,170
-29
-2% -$143
SDOT icon
2721
Sadot Group
SDOT
$18.5M
$6.96K ﹤0.01%
9
-1
-10% -$1.17K
ALGS icon
2722
Aligos Therapeutics
ALGS
$25.2M
$6.67K ﹤0.01%
402
BNBX
2723
DELISTED
BNB PLUS CORP
BNBX
$6.46K ﹤0.01%
1
BKKT.WS icon
2724
Bakkt Inc Warrants
BKKT.WS
$286K
$5.93K ﹤0.01%
17,976
BCLI
2725
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$5.74K ﹤0.01%
1,401
+325
+30% +$974

Similar funds

Creative Planning's Q4 2023 Portfolio in Review

As of Q4 2023, Creative Planning held 3,163 positions worth $53.9B, down 28% from $74.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Creative Planning's Q4 2023 filing shows 260 new, 1,432 increased, 926 reduced and 418 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M. The largest sale was iShares National Muni Bond ETF, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 5.2% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q4 2023 buy was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2023, an estimated $395M increase.
  • Creative Planning's biggest Q4 2023 reduction was iShares National Muni Bond ETF, cutting an estimated $105M.
  • Creative Planning fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $9.03M.
  • Creative Planning's ten largest holdings make up 32% of its $53.9B portfolio in Q4 2023.
  • Creative Planning opened 260 new positions and closed 418 in Q4 2023.
  • Creative Planning's portfolio value fell 28% quarter-over-quarter to $53.9B.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.